What are the clinical consequences of wait times for transcatheter aortic valve replacement?
A TAVR wait time of almost 3 months is associated with significant morbidity and mortality, highlighting the need for increased procedural capacity and access.
Postreimbursement wait time has remained unchanged for patients undergoing a TAVR procedure, suggesting the increase in capacity has kept pace with the increase in demand. The current wait time of almost 3 months is associated with important morbidity and mortality, suggesting a need for greater capacity and access.
Elbaz‐Greener et al. (Tue,) studied this question.